HOME >> MEDICINE >> NEWS
Other highlights in the April 21 JNCI

t density in healthy women has not been known. To investigate this, Jack Cuzick, Ph.D., of Cancer Research UK in London, and colleagues analyzed mammograms from 818 breast cancer-free women from the International Breast Cancer Intervention Study 1, a trial that tested tamoxifen's ability to prevent breast cancer in healthy women at high risk of the disease.

Treatment with tamoxifen was associated with reduced breast density, most of which occurred within the first 18 months of treatment. In women aged 45 years and younger, breast density was reduced by 13.4% on average compared with only 1.1% in women older than 55 years. The researchers hypothesize that premenopausal women experienced a larger reduction because premenopausal estrogen levels are higher and so the antiestrogenic effect of tamoxifen will be greater.

Contact: Press Office, Cancer Research UK, +44 (0) 207 061 8300, pressoffice@cancer.org.uk

Low Categories of Benign Breast Disease Still Increase Risk of Breast Cancer

There are several breast abnormalities that are not cancerous, but some of these benign conditions are associated with a greater risk of breast cancer than others. A new study has found that even women with low-category benign breast diseases are at an increased risk of breast cancer compared with women without the disease.

Jiping Wang, M.D., Ph.D., of the University of Pittsburgh, and colleagues looked at medical records for 11,307 women from the Breast Cancer Prevention Trial, 1376 of whom had the low-category benign breast disease. Women with the disease were 60% more likely than women without the disease to develop invasive breast cancer. Women with benign breast disease aged 50 years or older had a 95% increased risk of developing invasive breast cancer compared to women without benign breast disease.

Contact: Lori Garvey, National Surgical Breast and Bowel Project, (412)330-4621, <
'"/>

Contact: Sarah L. Zielinski
jncimedia@oupjournals.org
301-841-1287
Journal of the National Cancer Institute
20-Apr-2004


Page: 1 2 3 4

Related medicine news :

1. Other highlights in the March 16 JNCI
2. Other highlights in the March 2 JNCI
3. Other highlights in the February 2 JNCI
4. Other highlights in the January 19 JNCI
5. Other highlights in the December 15 JNCI
6. Other highlights in the December 1 JNCI
7. Other highlights in the September 15 JNCI
8. Other highlights in the April 7 JNCI
9. Other highlights in the January 7 issue of JNCI
10. Other highlights in the December 3 issue of JNCI
11. Other highlights in the November 19 issue of JNCI

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Other highlights the April JNCI

(Date:4/21/2015)... Texas (PRWEB) April 21, 2015 ... H1 2015” provides comparative analysis on the ... R&D pipelines by identifying new targets and ... Complete report with TOC is available @ ... also reviews key players involved in the ...
(Date:4/21/2015)... 2015 Angelo’s FabriClean has recently announced ... for clients that avail the area rug cleaning services. ... done with hi-tech equipments, making use of the quick ... all natural, high pressure steam extraction to clean even ... for area rugs made with delicate fabric. , ...
(Date:4/21/2015)... Information is the best weapon in the ... empowers patients and their families with knowledge about living with ... Cancer is the Answer" and new website . , ... guide patients from diagnosis through treatment and even death. The ... their treatment, at home and in the examination room. , ...
(Date:4/21/2015)... Somerset, NJ & New York, NY (PRWEB) April ... the leading global provider of advanced delivery technologies ... health products, today announced the launch of ADVASEPT™ ... the safe and efficient delivery of injectable medications. ... syringe, combining a safe, convenient and functional container ...
(Date:4/21/2015)... Lyft has announced the availability ... bringing the most advanced speech-recognition technology to another ... can now experience the full benefits of a ... the industry, Lyft, which offers value-added support services ... “Lyft is very excited to be able to ...
Breaking Medicine News(10 mins):Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 2Health News:Sinusitis Therapeutic Development and Pipeline Market Review H1 2015 Available at RnRMarketResearch.com 3Health News:Angelo’s FabriClean Now Offers Area Rug Cleaning in South Surrey with Complimentary Pick-Up and Delivery 2Health News:Authoritative guide and new accompanying therapeutic web portal bridge information gaps in cancer treatment 2Health News:Catalent Announces the Expansion of its Advanced, Aseptic, Glass-Free Injectable Platform with New ADVASEPT™ Lock Delivery Technology 2Health News:Lyft Expands Its Offerings to Include Dragon® Medical Practice Edition 2 for Otolaryngologists. 2
(Date:4/21/2015)... 21, 2015 The Natural Products Association ... supplement and natural products industry. NPA Senior Vice ... Hilmas , M.D., Ph.D., former Chief of the ... of Dietary Supplement Programs at the Food and ... to link dietary supplement intake with an increased ...
(Date:4/21/2015)... 21, 2015  Perrigo Company plc ("Perrigo") (NYSE: ... Directors has unanimously rejected the unsolicited Proposal (the "Proposal") ... April 8, 2015, to acquire all of the outstanding ... thorough review, advised by its financial and legal advisors, ... the Company and its future growth prospects and is ...
(Date:4/21/2015)... SAN DIEGO , 21. April 2015 ... Software für die quantitative Analyse des Hirnvolumens ... AG, einem weltweiten Pharmaunternehmen, bekannt geben zu ... des leistungsstarken NeuroQuant-Quantifizierungsreports des Hirnvolumens zusammenarbeiten, der ... von Hirnvolumen in Patienten mit multipler Sklerose ...
Breaking Medicine Technology:NPA Chief Scientist Comments on Research Associating Dietary Supplements with Increased Cancer Risk 2NPA Chief Scientist Comments on Research Associating Dietary Supplements with Increased Cancer Risk 3Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 2Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 3Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 4Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 5Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 6Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 7Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 8Perrigo Board Unanimously Rejects Unsolicited Proposal From Mylan 9CorTechs Labs kündigt Partnerschaft für die Bereitstellung umfassender Lösungen zur Quantifizierung des Verlustes von Hirnvolumen bei multipler Sklerose an 2
Cached News: